فضلا اضغط بالاسفل
يستعمل دواء diaflozimet 10/1000 mg 30 ext. rel . f.c. tabs. anti-diabetic.secretagogues.sglt2 inhibitors anti-diabetic.secretagogues.sglt2 inhibitors
mechanism of action -dapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (sglt2) which are responsible for at least 90% of the glucose reabsorption in the kidney. blocking this transporter mechanism causes blood glucose to be eliminated through the urine. in clinical trials dapagliflozin lowered hba1c by 0.6 versus placebo percentage points when added to metformin. - -dapagliflozin leads to heavy glycosuria
تركيبة دواءdiaflozimet 10/1000 mg 30 ext. rel . f.c. tabs.
يتركب هذا الدواء من :dapagliflozin+metformin
الشركة المنتجة لدواءdiaflozimet 10/1000 mg 30 ext. rel . f.c. tabs.
هذا الدواء من انتاج شركة eva pharma
جرعة دواء
Welcome to Dlildwa, specifically the page of diaflozimet 10/1000 mg 30 ext. rel . f.c. tabs..
تم استعراض بدائل هذا الدواء 469 مرة